Literature DB >> 18178751

Interleukin 3 and schizophrenia.

Xiangning Chen1, Kenneth S Kendler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18178751     DOI： 10.1176/appi.ajp.2007.07121868

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

Review 1.  Role and implications of nanodiagnostics in the changing trends of clinical diagnosis.

Authors:  Khalid Khalaf Alharbi; Yazeed A Al-Sheikh
Journal:  Saudi J Biol Sci       Date:  2013-11-19       Impact factor: 4.219

2.  PRENATAL INFECTION, MATERNAL IMMUNE ACTIVATION, AND RISK FOR SCHIZOPHRENIA.

Authors:  Sarah E Canetta; Alan S Brown
Journal:  Transl Neurosci       Date:  2012-12-01       Impact factor: 1.757

3.  Association between Interleukin 31 Receptor A Gene Polymorphism and Schizophrenia in Korean Population.

Authors:  Ju Yeon Ban; Su Kang Kim; Hak-Jae Kim; Joo-Ho Chung; Tae Kim; Jin Kyung Park; Hyun-Kyung Park; Jong Woo Kim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

4.  The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells.

Authors:  José A González-Feliciano; Marimar Hernández-Pérez; Luis A Estrella; Daisy D Colón-López; Armando López; Marina Martínez; Kirla R Maurás-Rivera; Clarivel Lasalde; Daviana Martínez; Félix Araujo-Pérez; Carlos I González
Journal:  PLoS One       Date:  2014-03-21       Impact factor: 3.240

5.  The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors.

Authors:  Xiong-jian Luo; Ming Li; Liang Huang; Kwangsik Nho; Min Deng; Qiang Chen; Daniel R Weinberger; Alejandro Arias Vasquez; Mark Rijpkema; Venkata S Mattay; Andrew J Saykin; Li Shen; Guillén Fernández; Barbara Franke; Jing-chun Chen; Xiang-ning Chen; Jin-Kai Wang; Xiao Xiao; Xue-bin Qi; Kun Xiang; Ying-Mei Peng; Xiang-yu Cao; Yi Li; Xiao-dong Shi; Lin Gan; Bing Su
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.